EE200300585A - PDE4 inhibiitori ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks - Google Patents

PDE4 inhibiitori ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks

Info

Publication number
EE200300585A
EE200300585A EEP200300585A EEP200300585A EE200300585A EE 200300585 A EE200300585 A EE 200300585A EE P200300585 A EEP200300585 A EE P200300585A EE P200300585 A EEP200300585 A EE P200300585A EE 200300585 A EE200300585 A EE 200300585A
Authority
EE
Estonia
Prior art keywords
treatment
combination
pde4 inhibitor
anticholinergic agent
obstructive airways
Prior art date
Application number
EEP200300585A
Other languages
English (en)
Estonian (et)
Inventor
Yeadon Michael
W. Watson John
A. Armstrong Roisin
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0129396A external-priority patent/GB0129396D0/en
Priority claimed from GB0210240A external-priority patent/GB0210240D0/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of EE200300585A publication Critical patent/EE200300585A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP200300585A 2001-05-25 2002-05-24 PDE4 inhibiitori ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks EE200300585A (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29360601P 2001-05-25 2001-05-25
GB0129396A GB0129396D0 (en) 2001-12-07 2001-12-07 Pharmaceutical combination
GB0210240A GB0210240D0 (en) 2002-05-03 2002-05-03 Pharmaceutical combination
PCT/EP2002/005726 WO2002096463A1 (en) 2001-05-25 2002-05-24 A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases

Publications (1)

Publication Number Publication Date
EE200300585A true EE200300585A (et) 2004-04-15

Family

ID=27256347

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300585A EE200300585A (et) 2001-05-25 2002-05-24 PDE4 inhibiitori ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks

Country Status (25)

Country Link
US (1) US20040147544A1 (pl)
EP (1) EP1395288A1 (pl)
JP (1) JP2005508861A (pl)
KR (1) KR20040007605A (pl)
CN (1) CN1511042A (pl)
AP (1) AP2003002909A0 (pl)
BG (1) BG108382A (pl)
BR (1) BR0209992A (pl)
CA (1) CA2446613A1 (pl)
CO (1) CO5640041A2 (pl)
CR (1) CR7152A (pl)
CZ (1) CZ20033150A3 (pl)
EE (1) EE200300585A (pl)
HU (1) HUP0400037A2 (pl)
IL (1) IL158776A0 (pl)
MA (1) MA27027A1 (pl)
MX (1) MXPA03010162A (pl)
NO (1) NO20035204D0 (pl)
NZ (1) NZ529335A (pl)
OA (1) OA12610A (pl)
PA (1) PA8546001A1 (pl)
PL (1) PL367085A1 (pl)
SK (1) SK14312003A3 (pl)
TN (1) TNSN03123A1 (pl)
WO (1) WO2002096463A1 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
WO2004084896A1 (en) * 2003-03-28 2004-10-07 Altana Pharma Ag Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
CA2519682A1 (en) * 2003-03-28 2004-10-07 Altana Pharma Ag Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
RU2006132043A (ru) * 2004-02-06 2008-03-20 МЕДА Фарма ГмбХ унд Ко.КГ (DE) Комбинация и фармацевтический препарат для лечения ринита
ES2413011T3 (es) 2004-02-06 2013-07-15 Meda Pharma Gmbh & Co. Kg Combinación de anticolinérgicos y glucocorticoides para el tratamiento a largo plazo de asma y EPOC
EP1713471B1 (en) * 2004-02-06 2012-01-18 MEDA Pharma GmbH & Co. KG Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
WO2005102344A1 (ja) * 2004-04-27 2005-11-03 Kyowa Hakko Kogyo Co., Ltd. 医薬組成物
EP1634595B1 (en) * 2004-08-19 2008-08-13 Rottapharm S.p.A. N-Phenylbenzamide derivatives as drugs for the treatment of Chronic Obstructive Pulmonary Disease (COPD)
EP1863476B1 (en) 2005-03-16 2016-02-03 MEDA Pharma GmbH & Co. KG The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
GB0511066D0 (en) * 2005-05-31 2005-07-06 Novartis Ag Organic compounds
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
KR100696432B1 (ko) * 2005-08-31 2007-03-19 김용환 건강진단용 팬티
BRPI0617673C1 (pt) * 2005-10-19 2012-05-22 Ranbaxy Lab Ltd composições de inibidores de fosfodiesterase do tipo iv
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
NZ591969A (en) 2005-12-21 2012-05-25 Meda Pharma Gmbh & Co Kg Combination of anticholinergics, glucocorticoids, beta2-adrenoceptor agonists, PDE 4 inhibitor and antileukotriene for the treatment of inflammatory diseases
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552407A (en) * 1993-06-11 1996-09-03 New York University Medical Center Anhydroecgonine compounds and their use as anticholinergic agents
ES2172583T3 (es) * 1995-06-06 2002-10-01 Pfizer 5,6-dihidro-9h-pirazol(3,4-c)-1,2,4-triazol(4,3-alfa)piridinas triciclicas.
US20020193393A1 (en) * 2001-03-07 2002-12-19 Michel Pairet Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors

Also Published As

Publication number Publication date
CA2446613A1 (en) 2002-12-05
KR20040007605A (ko) 2004-01-24
NO20035204D0 (no) 2003-11-24
IL158776A0 (en) 2004-05-12
WO2002096463A1 (en) 2002-12-05
AP2003002909A0 (en) 2003-12-31
CR7152A (es) 2004-02-23
JP2005508861A (ja) 2005-04-07
BG108382A (bg) 2004-12-30
CZ20033150A3 (cs) 2004-06-16
CN1511042A (zh) 2004-07-07
NZ529335A (en) 2005-09-30
MXPA03010162A (es) 2004-03-10
OA12610A (en) 2006-06-09
EP1395288A1 (en) 2004-03-10
US20040147544A1 (en) 2004-07-29
PA8546001A1 (es) 2003-12-30
HUP0400037A2 (hu) 2004-04-28
PL367085A1 (pl) 2005-02-21
SK14312003A3 (sk) 2004-08-03
MA27027A1 (fr) 2004-12-20
CO5640041A2 (es) 2006-05-31
TNSN03123A1 (en) 2005-12-23
BR0209992A (pt) 2004-04-06

Similar Documents

Publication Publication Date Title
EE200300585A (et) PDE4 inhibiitori ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks
EE200300586A (et) Adenosiini A2A retseptori agonisti ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks
PL362477A1 (pl) Inhibitory reduktazy HMG-CoA i sposób leczenia
NO20041833L (no) Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet
CY2013039I1 (el) Φθοροϋποκατεστημενη ωμεγα-καρβοξυαρυλ διφαινυλ ουρια για τη θεραπεια και προληψη ασθενειων και καταστασεων
NO20033594L (no) Fenetanolamin-derivater for behandling av luftveissykdommer
CY2014019I1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
IL160017A0 (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
NO20041272L (no) Tetracycline derivatives and methods of use thereof
PT1411926E (pt) Inibidores de integrina para o tratamento de doencas oftalmicas
AU2002353777A1 (en) Saliva-based methods for preventing and assessing the risk of diseases
EE200300473A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IL159379A0 (en) Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases
EE200300328A (et) IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks
NO20033801D0 (no) Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser
PL375564A1 (pl) Podstawione 5-chroman-5-ylo-etyloaminy i ich zastosowanie do leczenia jaskry
AU2002366028A1 (en) Use of fk506 and analogues for treating allergic diseases
PL369736A1 (pl) Nowe kompozycje leków na bazie antycholinergików oraz inhibitorów kinazy EGFR
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
EE200200698A (et) Ravimid neurodegeneratiivsete haiguste ennetamiseks ja raviks
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
EE200200240A (et) Lämmastikoksiidi kasutamine hingamisteede ahenemise raviks